| Literature DB >> 26055257 |
Kazuaki Miyamoto1, Soshi Seike2, Teruhisa Takagishi3, Kensuke Okui4, Masataka Oda5, Masaya Takehara6, Masahiro Nagahama7.
Abstract
BACKGROUND: Most recent studies of Clostridium perfringens plasmids have focused on toxin-encoding or antibiotic resistance plasmids. To cause intestinal disease, a toxigenic strain must grow in the intestines to levels allowing for sufficient toxin production and this in vivo growth often involves overcoming the normal intestinal microbial population. For this purpose, bacteriocin production might be important.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26055257 PMCID: PMC4459074 DOI: 10.1186/s12866-015-0443-3
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 2a Schematic comparison of the newly identified replication and partitioning region on: I) C. perfringens plasmid pBCNF5603 of F5603, II) C. perfringens plasmid pCP13 of strain 13, or III) C. perfringens plasmid pCP8533cpb of NCTC8533. The yellow boxes show ORFs on the putative rep gene, and blue boxes show conserved genes in the putative partitioning region; the smallest boxes show the region of a putative parS sequence. HP depicts the genes encoding a hypothetical protein, and CHP depicts the gene encoding a conserved hypothetical protein. Shaded bars show the region inserted in pKZ200 (upper bar) or pKZ210 (lower bar). b Schematic comparison of the putative replication region on: I) C. perfringens plasmid pBCNF5603 of F5603, II) C. perfringens plasmid pCP8533S12 of NCTC8533. The yellow boxes show the putative rep genes, and orange box shows a putative deleted region of a putative rep gene on pBCNF5603, which is homologous to the rep gene on pIP404 or on pCP8533S12, or III) C. perfringens plasmid pIP404 of CPN50
Plasmids constructed and used in this study
| Plasmid | |
|---|---|
| pJIR750 | HindIII/EcoRV (2629 bp) fragment of pIP404 replication region |
| pKZ100 | pJIR750 (XmnI/SpeI) Ω pBCNF5603 PCR product (SpeI/SnaBI; 3120 bp) ( |
| pKZ110 | pJIR750 (XmnI/SpeI) Ω pCP8533S12 PCR product (BsmI/PflMI; 2632 bp) ( |
| pKZ200 | pJIR750 (XmnI/SpeI) Ω pBCNF5603 PCR product (AvrII/BstBI; 5476 bp) (PCP63, |
| pKZ210 | pJIR750 (XmnI/SpeI) Ω pBCNF5603 PCR product (AvrII/HpaI; 2271 bp) (PCP63 fragment) |
Fig. 1Genetic organization of predicted ORFs on pBCNF5603. Above the line, the orientation of putative ORFs is left to right, while under the line, it is the opposite. Green boxes depict the ORFs homologous to that on pCP13, and red boxes depict those homologous to that on pIP404. Sequences of pCP13 and pIP404 have been reported previously [15, 16]
Fig. 3Repeated elements in the upstream region of the identified rep genes on pBCNF5603 and of the PCP63 homologs of other plasmids. The arrow-headed bars depict the five pairs of inverted repeats (IR1 to IR5). The rep gene ORF starts next to the final nucleotide
Similarity of the genes on the replication and partitioning region among C. perfringens plasmids carrying PCP63 homolog
| PCP63 homologs |
|
|
| PCP03 homologs | |||||
|---|---|---|---|---|---|---|---|---|---|
| ORF size | Identitya | ORF size | Identitya | ORF size | Identitya | length | ORF size | Identitya | |
| pBCNF5603 | 852 bp | 100 % | 753 bp | 100 % | 1278 bp | 100 % | 117 bp | 363 bp | 100 % |
| pCP13 | 906 bp | 92 % | 753 bp | 99 % | 1281 bp | 96 % | 117 bp | 363 bp | 94 % |
| pCP-TS1 | 918 bp | 91 % | 753 bp | 97 % | 1281 bp | 99 % | 117 bp | 363 bp | 90 % |
| pCP-OS1 | 918 bp | 90 % | 753 bp | 97 % | 1281 bp | 99 % | 117 bp | 363 bp | 90 % |
| pF262B | 906 bp | 93 % | 753 bp | 99 % | 1278 bp | 100 % | 117 bp | 363 bp | 99 % |
| pWAL-14572 | 906 bp | 93 % | 753 bp | 99 % | 1278 bp | 100 % | 117 bp | 363 bp | 99 % |
| pCP8533cpb | - | - | 753 bp | 98 % | 1281 bp | 96 % | 117 bp | 363 bp | 96 % |
| JGS1945cpb | - | - | 753 bp | 99 % | 1281 bp | 96 % | 117 bp | 363 bp | 95 % |
a: Substitutional amino acid identity
Stability of a recombinant plasmid, pKZ200, and plasmids, pBCNF5603 and pCP13, in C. perfringens strains
| Incidence of colonies carrying a recombinant plasmid, pKZ200, in ATCC3624 strain | ||
|---|---|---|
| Rate of Cp resistant colonies* | ||
| clone 1 | Culture with Cp | 92 % |
| Culture without Cp | 40 % | |
| clone 2 | Culture with Cp | 84 % |
| Culture without Cp | 44 % | |
| Incidence of colonies carrying a ecombinant plasmid, pKZ200, in strain 13 | ||
| Rate of Cp resistant colonies* | ||
| clone 1 | Culture with Cp | 80 % |
| Culture without Cp | 40 % | |
| clone 2 | Culture with Cp | 96 % |
| Culture without Cp | 44 % | |
| Incidence of colonies carrying a bacteriosin gene ( | ||
| Rate of PCR positive colonies*, # | ||
| clone 1 | PCR for the rep gene | 100 % |
| PCR for the bcn5603 gene | 100 % | |
| clone 2 | PCR for the rep gene | 100 % |
| PCR for the bcn5603 gene | 100 % | |
| Incidence of colonies carrying the beta2 toxin gene-encoding plasmid, pCP13, in strain 13 | ||
| Rate of PCR positive colonies*, # | ||
| clone 1 | PCR for the | 100 % |
| PCR for the | 100 % | |
| clone 2 | PCR for the | 100 % |
| PCR for the | 100 % | |
Culture samples with or without 10 µg/ml chloramphenicol were collected after ~60 generations
*: Rate of randomly selected colonies
#: To investigate the presence of pBCNF5603 in F5603 strain or pCP13 in strain13, randomly selected colonies were tested with colony PCR assay for three genes, rep (PCP63), bcn5603, and cpb2 genes. Colony PCR reactions were performed under the same conditions as described in the plasmid compatibility section